Skin Cancer & Melanoma

Latest News

Phase 1 data support the application for cosibelimab as a treatment for those with metastatic or locally advanced cutaneous squamous cell carcinoma.
BLA Resubmitted for Cosibelimab in Advanced Squamous Cell Carcinoma

July 2nd 2024

Phase 1 data support the application for cosibelimab as a treatment for those with metastatic or locally advanced cutaneous squamous cell carcinoma.

DRKASCH/WIRESTOCK CREATORS - STOCK.ADOBE.COM
A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A Mutation

June 12th 2024

Data show responses lasting for more than 6 months among patients with melanoma who responded to treatment with RP1 plus nivolumab.
RP1/Nivolumab Yields Responses in Previously Treated Melanoma

June 7th 2024

Phase 3 findings show the benefit of immunotherapy before surgery in those with macroscopic stage III node-positive melanoma.
Nivolumab Combo Improves EFS in Stage III Melanoma

June 2nd 2024

Subgroup findings suggest a PFS benefit with the addition of encorafenib/binimetinib in patients with liver metastases.
Encorafenib Regimen Shows No PFS Improvement in Metastatic BRAF+ Melanoma

June 1st 2024